Virtu Financial’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,014
| Closed | -$477K | – | 1562 |
|
|
2025
Q1 | $477K | Buy |
+14,014
| New | +$477K | 0.03% | 507 |
|
|
2024
Q4 | – | Sell |
-7,734
| Closed | -$363K | – | 1626 |
|
|
2024
Q3 | $363K | Sell |
7,734
-2,211
| -22% | -$104K | 0.02% | 557 |
|
|
2024
Q2 | $537K | Sell |
9,945
-53,797
| -84% | -$2.9M | 0.04% | 426 |
|
|
2024
Q1 | $4.35M | Buy |
63,742
+32,880
| +107% | +$2.24M | 0.33% | 44 |
|
|
2023
Q4 | $1.93M | Buy |
30,862
+17,186
| +126% | +$1.08M | 0.15% | 100 |
|
|
2023
Q3 | $621K | Sell |
13,676
-12,907
| -49% | -$586K | 0.06% | 284 |
|
|
2023
Q2 | $1.49M | Buy |
+26,583
| New | +$1.49M | 0.11% | 140 |
|
|
2022
Q4 | – | Sell |
-13,777
| Closed | -$900K | – | 1705 |
|
|
2022
Q3 | $900K | Sell |
13,777
-42,534
| -76% | -$2.78M | 0.08% | 219 |
|
|
2022
Q2 | $3.42M | Buy |
56,311
+33,910
| +151% | +$2.06M | 0.29% | 52 |
|
|
2022
Q1 | $1.41M | Buy |
22,401
+11,525
| +106% | +$723K | 0.1% | 156 |
|
|
2021
Q4 | $824K | Buy |
+10,876
| New | +$824K | 0.08% | 224 |
|
|
2021
Q2 | – | Sell |
-21,000
| Closed | -$2.56M | – | 1596 |
|
|
2021
Q1 | $2.56M | Buy |
+21,000
| New | +$2.56M | 0.18% | 72 |
|
|
2018
Q2 | – | Sell |
-5,352
| Closed | -$245K | – | 2038 |
|
|
2018
Q1 | $245K | Buy |
+5,352
| New | +$245K | 0.01% | 1205 |
|